Robin Carhart-Harris

Scientific Advisor at Entheon Biomedical

Robin Heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College, London, where he has designed a number of functional brain imaging studies with psychedelic compounds, plus a clinical trial of psilocybin targeting treatment resistant depression. Robin has over 50 published papers in peer-reviewed scientific journals; two of which were ranked in the top 100 most impactful academic articles of 2016.

Dr Carhart-Harris obtained his PhD in Psychopharmacology from the University of Bristol, and prior to that, an MA in Psychoanalysis at Brunel University. He has an honorary position at the University of Oxford.

Links

Timeline

  • Scientific Advisor

    Current role